News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AbbVie (ABBV) Accuses Novartis AG (NVS) Of Trying To Patent The Hep C Virus



4/4/2017 6:32:09 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
SAN FRANCISCO (CN) — A Chicagoland pharmaceutical company claims in court that Swiss drug giant Novartis “has sought to patent the hepatitis C virus, itself,” so that anyone who tries to study or cure the disease must license the Novartis patents.

In its March 31 federal complaint, AbbVie, of North Chicago sued Novartis Vaccines & Diagnostics and Grifols Worldwide Operations, of Spain and Ireland, claiming Novartis’ so-called “inventions” are based on “natural laws” and not patentable under U.S. Supreme Court precedent.

AbbVie challenges 11 patents relating to the study and treatment of hepatitis C.

Read at News Release
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES